Pirfenidone in pharma franchise in Kerala

Pirfenidone in PCD pharma franchise in Shillong

Pirfenidone in top pharma company in Solapur

Pirfenidone in pcd pharma supplier in Nellore

Pirfenidone in phama franchise company in India
Pirfenidone in phama distributor in Kochi

Home/Products /pirfenidone-200mg-tablet

Pifetol 200 tablet

Composition : Pirfenidone (200mg)

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 2x15

Price : ₹1/-

Pifetol 200 Tablet is a pharmaceutical product containing Pirfenidone, a medication primarily used in the treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease characterized by progressive scarring of the lung tissue. Pirfenidone is an anti-fibrotic agent that helps slow down the progression of lung fibrosis by reducing inflammation and the formation of scar tissue in the lungs, improving lung function and slowing the decline in lung capacity.

Pirfenidone works by modulating the growth factors and cytokines involved in fibrosis and inflammation, leading to a reduction in the activity of the fibrotic process. It is believed to act by inhibiting the production of transforming growth factor-beta (TGF-β), a key driver of fibrotic activity, and reducing the synthesis of collagen. This helps improve the quality of life for patients suffering from IPF and may prolong survival by reducing the rate of lung function decline.

In addition to its effectiveness in IPF, Pirfenidone is being researched for other fibrotic conditions, but it is currently approved for use in the management of IPF. Patients taking Pifetol 200 Tablet may experience benefits in lung function, but consistent monitoring and regular follow-ups with healthcare providers are essential.

Read More

About the Product

Pifetol 200 Tablet is a pharmaceutical product containing Pirfenidone, a medication primarily used in the treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease characterized by progressive scarring of the lung tissue. Pirfenidone is an anti-fibrotic agent that helps slow down the progression of lung fibrosis by reducing inflammation and the formation of scar tissue in the lungs, improving lung function and slowing the decline in lung capacity.

Pirfenidone works by modulating the growth factors and cytokines involved in fibrosis and inflammation, leading to a reduction in the activity of the fibrotic process. It is believed to act by inhibiting the production of transforming growth factor-beta (TGF-β), a key driver of fibrotic activity, and reducing the synthesis of collagen. This helps improve the quality of life for patients suffering from IPF and may prolong survival by reducing the rate of lung function decline.

In addition to its effectiveness in IPF, Pirfenidone is being researched for other fibrotic conditions, but it is currently approved for use in the management of IPF. Patients taking Pifetol 200 Tablet may experience benefits in lung function, but consistent monitoring and regular follow-ups with healthcare providers are essential.

Common side effects include nausea, fatigue, anorexia, diarrhea, and liver enzyme abnormalities. Rare but serious side effects may include liver toxicity and skin reactions.

For the treatment of Idiopathic Pulmonary Fibrosis (IPF) to slow disease progression and improve lung function.

Regular liver function tests should be performed during treatment. Discontinue use if severe liver damage occurs.

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation